Found: 41
Select item for more details and to access through your institution.
Direction-Specific Disruption of Subcortical Visual Behavior and Receptive Fields in Mice Lacking the β2 Subunit of Nicotinic Acetylcholine Receptor.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 41, p. 12909, doi. 10.1523/JNEUROSCI.2128-09.2009
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality.
- Published in:
- EJNMMI Physics, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40658-020-00322-x
- By:
- Publication type:
- Article
Failure of iodine uptake in microscopic pulmonary metastases after recombinant human thyroid-stimulating hormone stimulation.
- Published in:
- World Journal of Nuclear Medicine, 2020, v. 19, n. 1, p. 61, doi. 10.4103/wjnm.WJNM_29_19
- By:
- Publication type:
- Article
Utility of head CT in the evaluation of vertigo/dizziness in the emergency department.
- Published in:
- Emergency Radiology, 2013, v. 20, n. 1, p. 45, doi. 10.1007/s10140-012-1071-y
- By:
- Publication type:
- Article
SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer--Use of Imaging Agents in Therapeutic Drug Development and Approval.
- Published in:
- Journal of Nuclear Medicine Technology, 2022, v. 50, n. 3, p. 1, doi. 10.2967/jnmt.122.264372
- By:
- Publication type:
- Article
SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer- Use of Imaging Agents in Therapeutic Drug Development and Approval.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Management of Challenging Radioiodine Treatment Protocols: A Case Series and Review of the Literature.
- Published in:
- 2020
- By:
- Publication type:
- journal article
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with <sup>18</sup>F-FDG.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267281
- By:
- Publication type:
- Article
Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267208
- By:
- Publication type:
- Article
Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266842
- By:
- Publication type:
- Article
Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1064, doi. 10.2967/jnumed.123.267208
- By:
- Publication type:
- Article
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with <sup>18</sup>F-FDG.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 938, doi. 10.2967/jnumed.123.267281
- By:
- Publication type:
- Article
Real-World Experience with <sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 5, p. 735, doi. 10.2967/jnumed.123.266842
- By:
- Publication type:
- Article
The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 409, doi. 10.2967/jnumed.123.266614
- By:
- Publication type:
- Article
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 204, doi. 10.2967/jnumed.122.264860
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Factors predicting metastatic disease in <sup>68</sup>Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.241174
- By:
- Publication type:
- Article
Intra-arterial Peptide Receptor Radionuclide Therapy using <sup>90</sup>Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.241273
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Factors predicting metastatic disease in <sup>68</sup>Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.241174
- By:
- Publication type:
- Article
Intra-arterial Peptide Receptor Radionuclide Therapy using <sup>90</sup>Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.241273
- By:
- Publication type:
- Article
Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Intra-arterial Peptide Receptor Radionuclide Therapy using 90Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors..
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.241273
- By:
- Publication type:
- Article
Factors predicting metastatic disease in 68Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.241174
- By:
- Publication type:
- Article
Intra-arterial Peptide Receptor Radionuclide Therapy using <sup>90</sup>Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.241273
- By:
- Publication type:
- Article
Factors predicting metastatic disease in <sup>68</sup>Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.241174
- By:
- Publication type:
- Article
Intra-arterial Peptide Receptor Radionuclide Therapy using <sup>90</sup>Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.241273
- By:
- Publication type:
- Article
Factors predicting metastatic disease in <sup>68</sup>Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.241174
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Factors predicting metastatic disease in <sup>68</sup>Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.241174
- By:
- Publication type:
- Article
Intra-arterial Peptide Receptor Radionuclide Therapy using <sup>90</sup>Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.241273
- By:
- Publication type:
- Article
Intra-arterial Peptide Receptor Radionuclide Therapy using <sup>90</sup>Y DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.241273
- By:
- Publication type:
- Article
Factors predicting metastatic disease in <sup>68</sup>Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.241174
- By:
- Publication type:
- Article
Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Factors predicting metastatic disease in 68Ga-PSMA-11 PET positive osseous lesions in prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.241174
- By:
- Publication type:
- Article
PSMA PET imaging in the diagnosis and management of prostate cancer.
- Published in:
- Abdominal Radiology, 2023, v. 48, n. 12, p. 3610, doi. 10.1007/s00261-023-04002-z
- By:
- Publication type:
- Article
Outcomes after high-dose radiation in the management of neuroendocrine neoplasms.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0252574
- By:
- Publication type:
- Article
Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction.
- Published in:
- Molecular Imaging, 2018, v. 17, p. 1, doi. 10.1177/1536012118811741
- By:
- Publication type:
- Article
A bicentric retrospective analysis of clinical utility of <sup>18</sup>F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 13, p. 4463, doi. 10.1007/s00259-021-05415-y
- By:
- Publication type:
- Article
Gallium-68 prostate-specific membrane antigen ([<sup>68</sup>Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13550-020-00720-3
- By:
- Publication type:
- Article
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S98, doi. 10.1002/alz.13453
- By:
- Publication type:
- Article